Wells Fargo’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $548M | Buy |
19,533,309
+834,673
| +4% | +$22.2M | 0.1% | 191 |
|
|
2025
Q4 | $466M | Sell |
18,698,636
-774,013
| -4% | -$19.5M | 0.08% | 207 |
|
|
2025
Q3 | $496M | Buy |
19,472,649
+373,371
| +2% | +$9.22M | 0.09% | 186 |
|
|
2025
Q2 | $463M | Sell |
19,099,278
-3,518,759
| -16% | -$82.1M | 0.1% | 192 |
|
|
2025
Q1 | $573M | Buy |
22,618,037
+383,566
| +2% | +$10M | 0.13% | 159 |
|
|
2024
Q4 | $590M | Buy |
22,234,471
+1,273,952
| +6% | +$34.6M | 0.13% | 150 |
|
|
2024
Q3 | $607M | Sell |
20,960,519
-302,785
| -1% | -$8.83M | 0.14% | 144 |
|
|
2024
Q2 | $595M | Buy |
21,263,304
+974,008
| +5% | +$26.8M | 0.14% | 144 |
|
|
2024
Q1 | $563M | Buy |
20,289,296
+1,394,910
| +7% | +$38.7M | 0.14% | 146 |
|
|
2023
Q4 | $544M | Sell |
18,894,386
-2,745,408
| -13% | -$83M | 0.14% | 147 |
|
|
2023
Q3 | $718M | Sell |
21,639,794
-1,191,054
| -5% | -$42.1M | 0.21% | 105 |
|
|
2023
Q2 | $837M | Buy |
22,830,848
+151,886
| +0.7% | +$5.91M | 0.23% | 97 |
|
|
2023
Q1 | $925M | Buy |
22,678,962
+31,503
| +0.1% | +$1.36M | 0.27% | 91 |
|
|
2022
Q4 | $1.16B | Buy |
22,647,459
+263,442
| +1% | +$12.6M | 0.35% | 72 |
|
|
2022
Q3 | $980M | Sell |
22,384,017
-515,234
| -2% | -$25M | 0.32% | 76 |
|
|
2022
Q2 | $1.2B | Sell |
22,899,251
-2,131,535
| -9% | -$109M | 0.37% | 64 |
|
|
2022
Q1 | $1.3B | Buy |
25,030,786
+1,957,061
| +8% | +$102M | 0.33% | 72 |
|
|
2021
Q4 | $1.36B | Sell |
23,073,725
-4,626,885
| -17% | -$229M | 0.34% | 64 |
|
|
2021
Q3 | $1.19B | Sell |
27,700,610
-2,196,247
| -7% | -$97.3M | 0.26% | 81 |
|
|
2021
Q2 | $1.17B | Buy |
29,896,857
+661,754
| +2% | +$25.7M | 0.26% | 82 |
|
|
2021
Q1 | $1.06B | Buy |
29,235,103
+834,177
| +3% | +$29.6M | 0.24% | 93 |
|
|
2020
Q4 | $1.05B | Sell |
28,400,926
-2,582,151
| -8% | -$94.7M | 0.25% | 86 |
|
|
2020
Q3 | $1.08B | Buy |
30,983,077
+926,862
| +3% | +$32.5M | 0.3% | 74 |
|
|
2020
Q2 | $932M | Buy |
30,056,215
+757,722
| +3% | +$25.7M | 0.27% | 81 |
|
|
2020
Q1 | $907M | Buy |
29,298,493
+933,005
| +3% | +$31.8M | 0.31% | 70 |
|
|
2019
Q4 | $1.05B | Buy |
28,365,488
+196,401
| +0.7% | +$7M | 0.28% | 73 |
|
|
2019
Q3 | $960M | Sell |
28,169,087
-10,293,369
| -27% | -$374M | 0.27% | 78 |
|
|
2019
Q2 | $1.58B | Sell |
38,462,456
-583,210
| -1% | -$23.2M | 0.45% | 39 |
|
|
2019
Q1 | $1.57B | Sell |
39,045,666
-3,024,972
| -7% | -$121M | 0.47% | 34 |
|
|
2018
Q4 | $1.74B | Buy |
42,070,638
+36,047
| +0.1% | +$1.5M | 0.58% | 23 |
|
|
2018
Q3 | $1.76B | Sell |
42,034,591
-1,657,596
| -4% | -$63.8M | 0.5% | 26 |
|
|
2018
Q2 | $1.5B | Sell |
43,692,187
-401,803
| -0.9% | -$13.7M | 0.45% | 29 |
|
|
2018
Q1 | $1.48B | Sell |
44,093,990
-681,349
| -2% | -$23.4M | 0.44% | 32 |
|
|
2017
Q4 | $1.54B | Buy |
44,775,339
+7,186,009
| +19% | +$245M | 0.44% | 32 |
|
|
2017
Q3 | $1.27B | Sell |
37,589,330
-3,582,609
| -9% | -$115M | 0.39% | 40 |
|
|
2017
Q2 | $1.31B | Buy |
41,171,939
+2,066,394
| +5% | +$65.2M | 0.42% | 37 |
|
|
2017
Q1 | $1.27B | Buy |
39,105,545
+3,310,109
| +9% | +$104M | 0.41% | 40 |
|
|
2016
Q4 | $1.1B | Buy |
35,795,436
+2,276,534
| +7% | +$69.5M | 0.39% | 42 |
|
|
2016
Q3 | $1.08B | Buy |
33,518,902
+3,196,728
| +11% | +$107M | 0.4% | 42 |
|
|
2016
Q2 | $1.01B | Buy |
30,322,174
+1,426,720
| +5% | +$45.5M | 0.39% | 45 |
|
|
2016
Q1 | $813M | Sell |
28,895,454
-1,766,024
| -6% | -$50.4M | 0.32% | 59 |
|
|
2015
Q4 | $939M | Buy |
30,661,478
+1,088,768
| +4% | +$34.3M | 0.37% | 48 |
|
|
2015
Q3 | $881M | Buy |
29,572,710
+2,953,260
| +11% | +$94.7M | 0.37% | 46 |
|
|
2015
Q2 | $847M | Buy |
26,619,450
+142,762
| +0.5% | +$4.65M | 0.33% | 53 |
|
|
2015
Q1 | $874M | Sell |
26,476,688
-2,537,632
| -9% | -$80.7M | 0.34% | 51 |
|
|
2014
Q4 | $857M | Buy |
29,014,320
+4,143,602
| +17% | +$119M | 0.34% | 55 |
|
|
2014
Q3 | $698M | Buy |
24,870,718
+328,196
| +1% | +$9.21M | 0.29% | 63 |
|
|
2014
Q2 | $691M | Buy |
24,542,522
+205,562
| +0.8% | +$5.86M | 0.28% | 62 |
|
|
2014
Q1 | $742M | Buy |
24,336,960
+649,203
| +3% | +$19.4M | 0.32% | 54 |
|
|
2013
Q4 | $688M | Buy |
23,687,757
+585,718
| +3% | +$17M | 0.3% | 62 |
|
|
2013
Q3 | $630M | Buy |
23,102,039
+521,236
| +2% | +$14.2M | 0.3% | 65 |
|
|
2013
Q2 | $600M | Buy |
+22,580,803
| New | +$624M | 0.31% | 57 |
|
Other funds holding PFE
VCM
VPM
Wells Fargo's PFE Position: Q1 2026 in Review
Wells Fargo increased its Pfizer (PFE) stake by 4.5% in Q1 2026, buying an estimated $22.2M and bringing the position to 19,533,309 shares worth $548M. The position accounts for 0.1% of the portfolio, ranked #191.
Wells Fargo first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.76B in Q3 2018. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Wells Fargo held 19,533,309 shares of Pfizer worth $548M as of Q1 2026.
- Wells Fargo bought 834,673 Pfizer shares in Q1 2026, an estimated $22.2M.
- Pfizer made up 0.1% of Wells Fargo's portfolio in Q1 2026, its #191 holding.
- Wells Fargo first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Pfizer position peaked at $1.76B in Q3 2018.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.